FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 149

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
HOWL Nasdaq Werewolf Therapeutics, Inc. 2834
IBIO Nasdaq iBio, Inc. 2834
IDYA Nasdaq IDEAYA Biosciences, Inc. 2834
IMA Nasdaq ImageneBio, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
IMRX Nasdaq Immuneering Corporation 2834
IMUX Nasdaq Immunic, Inc. 2834
IMVT Nasdaq Immunovant, Inc. 2834
INKT Nasdaq MiNK Therapeutics, Inc. 2834
INTS Nasdaq Intensity Therapeutics, Inc. 2834
IRLA Nasdaq IRulya Therapeutics Inc. 2834
JAGX Nasdaq Jaguar Health, Inc. 2834
JAZZ Nasdaq Jazz Pharmaceuticals plc 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KARD Nasdaq Kardigan, Inc. 2834
KNSA Nasdaq Kiniksa Pharmaceuticals International, p 2834
KROS Nasdaq Keros Therapeutics, Inc. 2834
KTTA Nasdaq Pasithea Therapeutics Corp. 2834
KYTX Nasdaq Kyverna Therapeutics, Inc. 2834
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2834
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2834
LIMN Nasdaq Liminatus Pharma, Inc. 2834
LLY New York Eli Lilly and Company 2834
LPCN Nasdaq Lipocine Inc. 2834
LQDA Nasdaq Liquidia Corporation 2834
LXEO Nasdaq Lexeo Therapeutics, Inc. 2834
LZAGY Over the counter Lonza Group AG 2834
MAIA NYSE American MAIA Biotechnology, Inc. 2834
MANE New York Veradermics, Incorporated 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
MDCX Nasdaq Medicus Pharma Ltd. 2834
MDGL Nasdaq Madrigal Pharmaceuticals, Inc. 2834
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2834
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2834
MPLT Nasdaq MapLight Therapeutics, Inc. 2834
MRK New York Merck & Co., Inc. 2834
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2834
NBIX Nasdaq Neurocrine Biosciences, Inc. 2834
NGEN Nasdaq NervGen Pharma Corp. 2834
NGNE Nasdaq Neurogene Inc. 2834
NMRA Nasdaq Neumora Therapeutics, Inc. 2834
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2834
NSRX NYSE American Nasus Pharma Ltd. 2834
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2834
NTLA Nasdaq Intellia Therapeutics, Inc. 2834
NTRB Nasdaq Nutriband Inc. 2834
NVCT Nasdaq Nuvectis Pharma, Inc. 2834
NVS New York Novartis AG 2834
OCGN Nasdaq Ocugen, Inc. 2834
OCS Nasdaq Oculis Holding AG 2834
Results 50 through 100 of 149